Pharmaceutical Business review

MiddleBrook Pharmaceuticals names new vice chairman

Mr Blyth has also been retained as a consultant. In this capacity he will provide strategic guidance in late-stage development and commercialization tactics. Mr Blyth has recently retired from his role as chairman of Diageo, which he held since July 2000.

John Thievon, president and CEO of MiddleBrook, said: “I am extremely pleased to have James join our board of directors as vice chairman, and I look forward to working with him to ensure the future success of MiddleBrook.”